Systolic blood pressures above 130 millimeters of mercury in middle age were associated with an increased risk of dementia later on, according to a longitudinal study published June 12 in the European Heart Journal.

Mutations in the CHD4 gene are known contributors to congenital heart defects. Biologists at the University of North Carolina School of Medicine believe they are beginning to understand why.

Coronary artery bypass graft (CABG) surgeries, in particular, were strongly linked to the life-threatening condition—carrying a 14-fold increase in relative risk, among the top five of all inpatient procedures analyzed.

An advanced blood test to diagnose heart attacks, currently in development by researchers at King’s College London, could be administered using a handheld device, according to research presented on June 5 at the British Cardiovascular Society conference in Manchester, U.K.

Erectile dysfunction (ED) is an independent predictor of cardiovascular disease (CVD), according to a research letter published June 11 in Circulation.

DALLAS, June 12, 2018 — The American Heart Association—the world’s leading voluntary organization dedicated to building healthier lives, free of cardiovascular diseases and stroke—announced today research grants totaling more than $28 million to the scientific teams that will create a new research network focused on understanding the causes of atrial fibrillation (AFib).

A new study published in PLOS Medicine suggests people prescribed a single-pill fixed-dose drug combination (FDC) to manage hypertension are more likely to be compliant with their medication and achieve better health outcomes than those taking separate pills.

The first coagulation monitoring device with built-in Bluetooth technology is expected to be commercially available this summer to warfarin patients in the United States, according to device-maker Roche Diagnostics.